DNTH icon

Dianthus Therapeutics
DNTH

Overview Fund Activity

52 hedge funds and large institutions have $11M invested in Dianthus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 25 closing their positions.

Holders
52
Holders Change
-20
Holders Change %
-27.78%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
16
Reduced
15
Closed
25
Calls
$10K
Puts
$2K
Net Calls
+$8K
Net Calls Change
+$8K

Top Buyers

1
HJMC
1
Hellman Jordan Management Company
Massachusetts
$174K
2
Millennium Management
2
Millennium Management
New York
$914K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$232K
4
Thrivent Financial for Lutherans
4
Thrivent Financial for Lutherans
Minnesota
$47K
5
BCM
5
Bridgeway Capital Management
Texas
$83.8K

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$0
2
RCM
2
RA Capital Management
Massachusetts
$0
3
TCM
3
TCG Crossover Management
California
$0
4
WP
4
Woodline Partners
California
$0
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Daiwa Securities Group
76
Daiwa Securities Group
Japan
– – -106 Closed
UB
77
UMB Bank
Missouri
$0 742 – –
CFGS
78
Concourse Financial Group Securities
Alabama
– – – –
1 2 3
4